Key Takeaways A one-year Parkinson’s stem cell trial called STEM-PD found no serious side effects linked to the cell product itself. Scientists used embryonic stem cells to grow dopamine producing cells, then transplanted them into eight patients with Parkinson’s disease. Six of seven surviving patients cut their Parkinson’s medication substantially,
Key Takeaways Biologic therapies help many people with Crohn’s disease, but some patients stop responding over time or cannot tolerate them. Mesenchymal stem cells are the main type of stem cell treatments studied for Crohn’s, particularly for complex perianal fistulas. The only stem cell product ever approved for Crohn’s fistulas
Key Takeaways Traumatic brain injury (TBI) often causes lasting neurological deficits, since the brain has limited ability to repair itself after trauma. Stem cell therapy is being studied as a supportive treatment option that may calm inflammation and support the brain’s own repair signals. A Phase 2 controlled trial found
Key Takeaways Researchers at MUSC report that engineered mesenchymal stem cells reversed new-onset type 1 diabetes in mice, pointing to the disease’s immune response rather than just its symptoms. The cells were modified to overexpress a protein called alpha-1 antitrypsin, which calmed the autoimmune attack and protected insulin producing beta
Quick Summary In 2026, stem cell therapy for diabetes shows measurable improvement in 60-80% of patients, including better blood sugar control, reduced insulin use, and improved insulin resistance. Type 2 diabetes patients often respond better than type 1. However, full remission remains uncommon, and results depend on disease duration, treatment
Quick Read Summary Stem Cell Therapy For Diabetes Type 2: Can It Help Blood Sugar Control? Stem cell therapy is being studied as a potential way to improve insulin production and support blood sugar control in diabetes type 2. Early clinical trial results show some patients had lower blood sugar
